International Expert on Dengue Fever Delivers 20th Annual WINDREF Lecture

With 390 million dengue infections per year and 96 million more individuals showing symptoms, half of the world’s population is now at risk of contracting dengue virus, this according to Dr. Timothy Endy at the 20th annual WINDREF Lecture at St. George’s University. In his address, the chief of the Division of Infectious Diseases at SUNY Upstate Medical University outlined the history of dengue research in Thailand and shared his key findings and the future directions in the study of the disease.

Additionally, Dr. Endy not only came to Grenada to provide an overview of his research across almost three decades but as part of a proposed incidence study titled “Dengue in a Travel Population: Prospective Cohort Study of Primary Dengue Infection.” The study will examine dengue-naïve individuals who move to an endemic dengue area and are now at high risk for infection, while also offering an opportunity to study the immunology of primary infection.

Dr. Timothy Endy

“The Grenada prospective dengue study is the first of its kind, in that a primary prospective study has never been done,” stated Dr. Endy. “Understanding what happens during that first infection is so key and so understudied that it’s one of the main reasons why we’re doing it here at SGU.”

Funded by Janssen Global Public Health, a division of Janssen Pharmaceutica, the study began on August 2018 and will run until May 2021. Approximately 600 students are enrolled. They will provide blood samples for research surveillance throughout the year with the primary objective of determining what the incidence of dengue is within the student population, as well as the feasibility to support a prophylactic dengue efficacy trial.

“The study will focus on the incidence of infection of the dengue virus in the student body with hopes of providing a better understanding of the host response to the first dengue infection,” explained Dr. Endy. “Additionally, we hope it will help to refine diagnostic assays for dengue which is essential for diagnosing acute dengue and vaccine development; and be a platform in which to test the effectiveness of drugs and vaccines in a traveler’s population.”

As professor and chair of microbiology and immunology and vice chair of research in the Department of Medicine at Upstate, Dr. Endy is considered a renowned expert in the field of dengue and dengue hemorrhagic fever and emerging viral pathogens. During his longstanding career, he has conducted basic science research in the field of virology, developed vaccine field and epidemiological study sites in Southeast and Central Asia, conducted phase I and II clinical vaccine trials, and is active in the development and management of research programs that are product oriented towards developing vaccines and diagnostics that meet FDA regulatory requirements.

Formerly known as the annual Keith B. Taylor Memorial/WINDREF Lecture, the WINDREF Lecture attracts the attention of world experts willing to share their expertise on topics such as climate change, health needs, and drug abuse and addictions. Past speakers have included Dr. Robert C. Gallo, best known for his role in the discovery of the HIV’s link to AIDS; Dr. Ruth Macklin, a bioethics pioneer; and renowned cardiologist Dr. Valentin Fuster.

– Ray-Donna Peters

New NIH Grant Puts Focus on Zika Virus’ Effect on Child Neurodevelopment

The WINDREF building on SGU’s True Blue Campus

Three years after the Zika virus (ZIKV) epidemic swept through Grenada and the region, St. George’s University faculty members have secured a two-year grant from the US-based Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) to examine the effectiveness of a community intervention program aimed at improving neurodevelopment in Grenadian children exposed to the virus.

The new NIH-funded study will be administered by the non-profit Windward Islands Research and Education Foundation (WINDREF), which is based on the SGU campus in Grenada. Dr. Randall Waechter joins three other SGU faculty members—Drs. Barbara Landon, Karen Blackmon, and Trevor Noël—on a research team that also includes Dr. Michelle Fernandes, NIHR Academic Clinical Fellow in Paediatrics, Southampton University, and Honorary Research Fellow at Oxford University.

“This work could have a significant impact on the way we address neuropsychological impairment in children exposed to the Zika virus,” Dr. Waechter said. “If effective, there is no reason this intervention couldn’t be implemented in other countries impacted by the Zika virus.”

One of the most significant consequences of the ZIKV epidemic is the increased risk of adverse neurological developments in the children of ZIKV-infected mothers. These children, who are now 2 and 3 years old, are at high risk for chronic epilepsy as well as intellectual and learning disabilities. This study will provide valuable data on whether a culturally adapted and evidence-based project called Environmental Enrichment can rescue neurodevelopmental outcomes in toddlers who were exposed to ZIKV.

The research also presents a novel approach to assisting these children that may be applicable worldwide. It augments the ongoing Saving Brains Grenada program in Grenada, work that was funded by Grand Challenges Canada. The program has enabled community workers to interact with caregivers and their children, helping parents implement enjoyable Conscious Discipline-based ‘brain smart’ methods that foster neurodevelopment in young children. These methods focus on elements of child-raising such safety, attachment, and self regulation, in addition to early childhood stimulation. The Saving Brains Grenada team has been supported by Jhpiego, an international non-profit health organization affiliated with Johns Hopkins University.

Dr. Landon called the new NIH study a “natural fit” for the Saving Brains Grenada initiative.

“Our primary goal is to maximize brain development in children,” she said, “giving them the best chance for success across their entire lives.”